Production Assistance for Cellular Therapies
City of Hope’s Center for Biomedicine & Genetics (CBG) has been selected as one of the 5 Cell Processing Facilities offering translational services and cell product manufacturing for pre-clinical studies to investigators at no charge under the National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program.
September 22, 2016 - City of Hope to Manufacture Novel Cell Therapies
The 5 PACT Cell Processing Facilities & Coordinating Centers are:
- University of Minnesota Molecular and Cellular Therapeutics (MCT), HHSN268201600014I
- Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine, HHSN268201600015I
- Center for Biomedicine and Genetics, City of Hope, HHSN268201600011I
- Interdisciplinary Stem Cell Institute Cellular Manufacturing Program (ISCI-CMP), Miller School of Medicine, University of Miami, HHSN268201600012I
- Moffit Cancer Center and Research Institute, HSN268201600013I
- Coordinating Center-The Emmes Corporation, HHSN268201600020C
PACT's objective is to promote the advancement of cellular therapy research in the areas of regeneration of damaged/diseased tissues, organs, and biologic systems, and targeted treatments for serious diseases without effective therapies in support of the NHLBI's program areas of interest: cardiovascular, pulmonary, blood, hematopoietic, and stem cell disorders. For qualifying areas of interest, please see the PACT Application: Scope Criteria located at www.pactgroup.net.
The PACT program at City of Hope can provide:
- Neural stem cells
- Bacterial products
- hESC products
- iPSC products
- Islet cells
- Transduced T cells
- Monoclonal antibodies
- Baculovirus proteins
- Plasmid DNA
- Lentivirus
- Adenovirus
- Tranduced HPC
- Vaccinia virus
- Oncolytic VSV